US 10308941
Compositions and methods for inhibiting gene expression of factor XII
granted A61KA61K31/713A61K45/06
Quick answer
US patent 10308941 (Compositions and methods for inhibiting gene expression of factor XII) held by Arrowhead Pharmaceuticals, Inc. expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/713, A61K45/06, A61K47/42, A61K47/554